Infections by multidrug resistant organisms (MDROs) are a global health threat with a worrying increasing trend. In fragile ...

Aztreonam–avibactam is a promising treatment for complicated intra-abdominal infections and hospital-acquired or ...

LpxC inhibitors are emerging as a promising class of antibiotics targeting Gram-negative bacteria, which are notorious for their resistance to many existing antibiotics. LpxC, an essential enzyme ...

A team of researchers at the University of California, Los Angeles (UCLA) has introduced a virtual Gram staining technique that could transform how microbiologists stain and classify bacteria.

The initial use of combination antimicrobial therapy for gram-negative infections is usually ... risk of superinfection with more-resistant bacteria or fungi. There are no clinical data that ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today announced the ...

The development of nanodrugs targeting multidrug-resistant bacteria, while sparing the beneficial constituents of the microbiome, has emerged as a promising approach to combat disease and curb the ...

Preliminary data indicates patients experienced either a complete cure or significant improvement in infection symptoms following treatment with ...

They looked for any overlapping or co-occurrences of different bacteria—this allowed them to see if people with high levels of certain microbes had lower levels of others. These gram-negative ...

Jason B. Pieper, DVM, MS, DACVD, talked about pyoderma, including ingredients and formulations, in his lecture at the 2025 ...

When Dr. Irene Chen wraps up her day teaching courses and leading research, her work isn’t finished – she then heads back to ...

BV100 is a new formulation of rifabutin suitable for intravenous administration, which BioVersys claims offers a new ...